Above the 40 (March 8, 2017) – A Quiet Pre-Fed Breakdown for the Stock Market

AT40 = 43.3% of stocks are trading above their respective 40-day moving averages (DMAs) AT200 = 60.5% of stocks are trading above their respective 200DMAs VIX = 11.9 (volatility index) Short-term Trading Call: neutral Commentary Times like these really put AT40 (T2108), the percentage of stocks trading above their respective 40-day moving averages (DMAs), to … Read more

The Trump Volatility Trade: Nordstrom, Intel, Cognizant Technology, and Biotech

President Trump will address a joint session of Congress on Tuesday night, February 28th. Traders will no doubt have notepads ready to jot down the latest corporate targets of Trump’s wrath and praise. Trump’s words and tweets move markets, yet recent impacts have not lasted and have even worked in reverse of expectations. It is … Read more

T2108 Update (January 13, 2017) – The NASDAQ Shows Resolve While the S&P 500 Bearishly Grinds Away

(T2108 measures the percentage of stocks trading above their respective 40-day moving averages [DMAs]. It helps to identify extremes in market sentiment that are likely to reverse. To learn more about it, see my T2108 Resource Page. You can follow real-time T2108 commentary on twitter using the #T2108 hashtag. T2108-related trades and other trades are … Read more

T2108 Update (December 7, 2016) – The Major Overbought Breakout Arrives

(T2108 measures the percentage of stocks trading above their respective 40-day moving averages [DMAs]. It helps to identify extremes in market sentiment that are likely to reverse. To learn more about it, see my T2108 Resource Page. You can follow real-time T2108 commentary on twitter using the #T2108 hashtag. T2108-related trades and other trades are … Read more

T2108 Update (December 6, 2016) – The S&P 500 Flirts With A Major Overbought Breakout

(T2108 measures the percentage of stocks trading above their respective 40-day moving averages [DMAs]. It helps to identify extremes in market sentiment that are likely to reverse. To learn more about it, see my T2108 Resource Page. You can follow real-time T2108 commentary on twitter using the #T2108 hashtag. T2108-related trades and other trades are … Read more

The iShares Nasdaq Biotechnology (IBB) Overcomes Its First Bash

The iShares Nasdaq Biotechnology (IBB) suffered three important “bashes” starting in September, 2015 when Secretary of State Hillary Clinton promised to end price gouging by drug makers. Since then, a similar promise in August created a fresh top in IBB and a bash by Senator Bernie Sanders created a breakdown below 200-day moving average (DMA) … Read more

T2108 Update (October 28, 2016) – Divergences Weigh Further on the Stock Market

(T2108 measures the percentage of stocks trading above their respective 40-day moving averages [DMAs]. It helps to identify extremes in market sentiment that are likely to reverse. To learn more about it, see my T2108 Resource Page. You can follow real-time T2108 commentary on twitter using the #T2108 hashtag. T2108-related trades and other trades are … Read more

Mylan’s Other EpiPen Classification Issue and Unresolved Overhang

(This is an excerpt from an article I originally published on Seeking Alpha on October 19, 2016. Click here to read the entire piece.) Mylan (MYL) is down 13% (and as much as 17%) since I argued the company was “out of tune” with an angry chorus that promised to place a lot of short-term … Read more

A Fresh Breakdown for iShares Nasdaq Biotechnology (IBB)

Drug corporations' greed is unbelievable. Ariad has raised the price of a leukemia drug to almost $199,000 a year. https://t.co/EB4nEPxP2G — Bernie Sanders (@SenSanders) October 14, 2016 The drug industry is getting very, very nervous. We are going to take them on and lower the cost of medication across this country. https://t.co/6PeiLJnR0F — Bernie Sanders … Read more

Hate the Game, Not the Player? – Mylan Is Out of Tune Amid An Angry Chorus

(This is an excerpt from an article I originally published on Seeking Alpha on August 29, 2016. Click here to read the entire piece.) This is the message actress Sarah Jessica Parker posted on Instagram Thursday, August 25, 2016 to join a chorus of protest and complaint about the extremely high cost of the EpiPen® … Read more